
Sign up to save your podcasts
Or


The company that developed Cologuard also developed this “next generation” multitarget stool DNA test, and has applied for U.S. FDA approval. The new test appears to have similar sensitivity and higher specificity than its predecessor — which means fewer false positives.
https://www.nejm.org/doi/10.1056/NEJMoa2310336
By Questioning Medicine4.9
7474 ratings
The company that developed Cologuard also developed this “next generation” multitarget stool DNA test, and has applied for U.S. FDA approval. The new test appears to have similar sensitivity and higher specificity than its predecessor — which means fewer false positives.
https://www.nejm.org/doi/10.1056/NEJMoa2310336

7,639 Listeners

14,841 Listeners

135 Listeners

705 Listeners

506 Listeners

265 Listeners

2,446 Listeners

3,360 Listeners

56,508 Listeners

1,152 Listeners

28,325 Listeners

6,381 Listeners

373 Listeners

29,207 Listeners

1,360 Listeners